ARCHOS: Successful capital increase and oversubscription of 190.6% and end of any dilutive instrument – 05/15/2024 at 08:30


The capital increase launched on April 9, 2024 was oversubscribed by 190.6% and thus allows ARCHOS to put an end to any dilutive financing.

From now on, the number of shares is 58,053,021 of which the management holds the quorum at more than 25%.

The ARCHOS group is now focused on its strategic plan, which creates value:

Strategic plan 2024-2026:

Now with 3 pillars of high added value, the consumer market, the professional market and the medical market, the group intends to return to strong profitable growth over its 3-year plan:

  1. Seek hyper growth, preserve profitability and cash flow

    : reach €40M in turnover and profitable EBITDA in 2024. Exceed €50M in turnover in 2025 while significantly improving profitability

  1. Continue to innovate

    : at ARCHOS, for Christmas 2024, launch of a range of new and innovative solutions for the health, well-being and entertainment of our pets.

  1. Growing in technological solutions for defense

    by the internally reinforced expertise on strategic Defense subjects but also by the acquisition of small strategic BITD companies

  1. Realize beautiful and large projects with Health start-ups

    such as DOMISANTE, a simple gateway for monitoring constants, teleconsultation and tele-expertise from home for the benefit of aging well but also for monitoring chronic diseases

With a cash position of more than €10 million, the group does not rule out external growth in high value-added businesses.

The publication of the unaudited turnover will be on July 18 after market close and the half-year accounts will be published on August 8, 2024 after market close.

Contact Investors

Loïc Poirier – Chairman and CEO – [email protected]

————————————————– ————————————————– ————————————————


About ARCHOS

ARCHOS, an expert in mobile solutions, has constantly revolutionized this market both in the consumer electronics sector and in B to B with its subsidiary LOGIC INSTRUMENT. The French brand was the first to offer Google Android tablets in 2009. ARCHOS launched a MedTech division in 2021, Medical Devices Venture, which will bring together several start-ups. With a head office in France and offices in Europe and Asia, ARCHOS has established itself as a key pan-European player, listed on the Euronext Growth Paris market, ISIN Code: FR001400K061. archos.com


This publication has the “🔒 Actusnews SECURITY MASTER” service.


– SECURITY MASTER Key:

l2hrlZduk2eVlmtyl5htnJOUbWuUmZTImmTGl5dwk8fImnBlmW2WmMfIZnFmnWhq

– To control this key:

https://www.security-master-key.com.



Regulated information:


Inside information:

– Other press releases


Full and original press release in PDF format:

https://www.actusnews.com/news/85834-archos-cp-15-mai-2024.pdf

© Copyright Actusnews Wire

Receive future company press releases free of charge by email by subscribing to www.actusnews.com



Source link -86